My only point was if one is to believe Vertex Boceprevir is a very inferior Protease Inhibitor. In my opinion as a potential drug I would have Boceprevir ahead of 191 but if things play out how Vertex was implying Boceprevir may be a commercial flop.
Market Data 
Markets 
AI
